508 results on '"Bosenberg, Marcus W."'
Search Results
2. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
3. Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity
4. Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations
5. Frontiers in Pigment Cell and Melanoma Research
6. Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest
7. Frontiers in pigment cell and melanoma research
8. Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity
9. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
10. Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma
11. Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction
12. The state of melanoma: challenges and opportunities.
13. PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
14. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
15. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
16. Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors
17. Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle
18. Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas
19. IL-7R licenses a population of epigenetically poised memory CD8 + T cells with superior antitumor efficacy that are critical for melanoma memory
20. p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
21. Genetic Analysis of Pten and Ink4a/Arf Interactions in the Suppression of Tumorigenesis in Mice
22. Autophagy maintains tumour growth through circulating arginine
23. Setdb1-loss induces type-I interferons and immune clearance of melanoma
24. Supplementary Table 8 from Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
25. Supplemental Figure 7 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
26. Data from Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
27. Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
28. Supplemental Figure 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
29. Data from KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
30. Data from BRAF Inhibition Alleviates Immune Suppression in Murine Autochthonous Melanoma
31. Data from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
32. Supplemental Figure 9 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
33. Supplemental Figure 5 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
34. Supplementary Tables 1-7, 9 from Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
35. Supplemental Figure 4 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
36. Supplemental Figure 2 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
37. Supplemental Figure 6 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
38. Supplemental Figure 3 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
39. Supplementary Figures 1 - 4 from BRAF Inhibition Alleviates Immune Suppression in Murine Autochthonous Melanoma
40. Supplementary Methods, Figure Legends, Tables S1 - S3 from Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
41. Supplementary Figure S7 from Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
42. Figure S1-S4 and Table S1-S2 from KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
43. Supplemental Table 1 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
44. Supplemental Figure 8 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
45. Supplementary Figure Legends from BRAF Inhibition Alleviates Immune Suppression in Murine Autochthonous Melanoma
46. Supplementary Figures 1-7 from Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
47. Supplemental Figure Legends from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
48. Data from Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
49. Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
50. Supplementary Figure Legend from Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.